Skip to content
MV BioTherapeutics SA
ApyraMed and ApyraVax technology
MV BioTherapeutics SA
  • Home
  • Programs
  • Technology
    • ApyraMed
    • ApyraVax
  • News & Events
  • About
  • Jobs
  • Contact
Search:
Linkedin page opens in new window
  • Home
  • Programs
  • Technology
    • ApyraMed
    • ApyraVax
  • News & Events
  • About
  • Jobs
  • Contact

Author Archives: admin

Oct62025

Secretory IgA amplification during immune checkpoint blockade enhances the control of tumor growth by enterotropic T cells

Read more
Nov282024

Prenatal antibiotics reduce breast milk IgA and induce dysbiosis in mouse offspring, increasing neonatal susceptibility to bacterial sepsis

Read more
Jul32024

Protection from environmental enteric dysfunction and growth improvement in malnourished newborns by amplification of secretory IgA

Read more
Feb112023

MV BioTherapeutics presented at the 7th Microbiome Movement – Drug Development Europe

Read more
Jul192022

Apyrase-mediated amplification of secretory IgA promotes intestinal homeostasis

Read more
Nov152021

MV BioTherapeutics to present at the 6th Microbiome Movement – Drug Development Europe

Read more
Mar232021
MV BioTherapeutics ApyraVax

MV Biotherapeutics and Malcisbo agree to explore the Apyrase technology platform for AH Vaccines

Read more
Jan192021

MV BioTherapeutics to present at 5th Microbiome Movement – Drug Development Europe

Read more
Aug312020
Sachs Forum 2020

20th Annual Biotech in Europe Forum for global partnering & investments

Read more
Jul32020

Succesfull Bio Digital 2020

Read more
→12→
Address
  • MV BioTherapeutics SA
    Via Belsoggiorno 1
    6500 Bellinzona
    Switzerland
Contact Info
  • E-mail:
    info@mv-bio.com
  • Networks:

Find us on:

Linkedin page opens in new window
Terms of use
  • Disclaimer
  • Privacy notice
  • Cookie notice
Menu
  • Home
  • Programs
  • Technology
    • ApyraMed
    • ApyraVax
  • News & Events
  • About
  • Jobs
  • Contact
MV BioTherapeutics SA
© MV BioTherapeutics SA

Powered by madball.ch

Go to Top
This website uses cookies
We use cookies that are strictly necessary to operate this website. We also use optional cookies to improve your accessibility to our website and its functionality, to analyse and track your use of our website and to give you the best possible user experience. You are free to decide which cookies you would like to permit. A default 'no consent' option applies in case no choice is made. For more detailed information on our use of cookies on this website, please read our Cookie notice.

ACCEPT Read More Cookie settings
Privacy & Cookies Policy

MV BioTherapeutics privacy overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT